HEADER MEMBRANE PROTEIN, ISOMERASE/INHIBITOR 06-APR-19 6OHU TITLE STRUCTURE OF EBP AND TAMOXIFEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-BETA-HYDROXYSTEROID-DELTA(8),DELTA(7)-ISOMERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: CHOLESTENOL DELTA-ISOMERASE,DELTA(8)-DELTA(7) STEROL COMPND 5 ISOMERASE,D8-D7 STEROL ISOMERASE,EMOPAMIL-BINDING PROTEIN, EBP; COMPND 6 EC: 5.3.3.5; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EBP; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS MEMBRANE PROTEIN, ISOMERASE, ISOMERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.LONG,X.LI REVDAT 2 13-MAR-24 6OHU 1 REMARK REVDAT 1 19-JUN-19 6OHU 0 JRNL AUTH T.LONG,A.HASSAN,B.M.THOMPSON,J.G.MCDONALD,J.WANG,X.LI JRNL TITL STRUCTURAL BASIS FOR HUMAN STEROL ISOMERASE IN CHOLESTEROL JRNL TITL 2 BIOSYNTHESIS AND MULTIDRUG RECOGNITION. JRNL REF NAT COMMUN V. 10 2452 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 31165728 JRNL DOI 10.1038/S41467-019-10279-W REMARK 2 REMARK 2 RESOLUTION. 3.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.7 REMARK 3 NUMBER OF REFLECTIONS : 13685 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.278 REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.326 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1369 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.8036 - 7.5880 0.99 1569 175 0.3069 0.3345 REMARK 3 2 7.5880 - 6.0266 0.98 1471 163 0.3181 0.3468 REMARK 3 3 6.0266 - 5.2659 1.00 1485 165 0.3312 0.3706 REMARK 3 4 5.2659 - 4.7849 1.00 1455 162 0.2571 0.2915 REMARK 3 5 4.7849 - 4.4422 1.00 1450 161 0.2392 0.3035 REMARK 3 6 4.4422 - 4.1805 1.00 1457 162 0.2445 0.2901 REMARK 3 7 4.1805 - 3.9712 1.00 1446 161 0.2508 0.3477 REMARK 3 8 3.9712 - 3.7984 0.94 1364 151 0.2655 0.3375 REMARK 3 9 3.7984 - 3.6523 0.42 603 67 0.2907 0.3422 REMARK 3 10 3.6523 - 3.5263 0.01 16 2 0.2999 0.6981 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.510 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5404 REMARK 3 ANGLE : 0.927 7389 REMARK 3 CHIRALITY : 0.048 798 REMARK 3 PLANARITY : 0.006 891 REMARK 3 DIHEDRAL : 9.646 2931 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -26.2380 -4.1270 43.7791 REMARK 3 T TENSOR REMARK 3 T11: 0.2630 T22: 0.1856 REMARK 3 T33: 0.1185 T12: -0.1505 REMARK 3 T13: 0.3134 T23: 0.1714 REMARK 3 L TENSOR REMARK 3 L11: -0.0294 L22: 0.1007 REMARK 3 L33: 0.3898 L12: 0.0332 REMARK 3 L13: 0.5832 L23: -0.9590 REMARK 3 S TENSOR REMARK 3 S11: -0.0110 S12: -0.0765 S13: -0.1307 REMARK 3 S21: -0.2933 S22: 0.1066 S23: 0.1958 REMARK 3 S31: 0.0375 S32: -0.1890 S33: -0.0084 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OHU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-19. REMARK 100 THE DEPOSITION ID IS D_1000240717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0,979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13685 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.57 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES, PEG 600, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 96.41850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.41450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 96.41850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.41450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -66.82900 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 TRP A -6 REMARK 465 SER A -5 REMARK 465 HIS A -4 REMARK 465 PRO A -3 REMARK 465 GLN A -2 REMARK 465 PHE A -1 REMARK 465 GLU A 0 REMARK 465 LYS A 1 REMARK 465 THR A 2 REMARK 465 THR A 3 REMARK 465 ASN A 4 REMARK 465 ALA A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 53 REMARK 465 ALA A 54 REMARK 465 VAL A 55 REMARK 465 VAL A 56 REMARK 465 PRO A 57 REMARK 465 LEU A 58 REMARK 465 GLY A 59 REMARK 465 ALA A 220 REMARK 465 LYS A 221 REMARK 465 ALA A 222 REMARK 465 THR A 223 REMARK 465 LYS A 224 REMARK 465 ALA A 225 REMARK 465 LYS A 226 REMARK 465 SER A 227 REMARK 465 LYS A 228 REMARK 465 LYS A 229 REMARK 465 ASN A 230 REMARK 465 MET B -7 REMARK 465 TRP B -6 REMARK 465 SER B -5 REMARK 465 HIS B -4 REMARK 465 PRO B -3 REMARK 465 GLN B -2 REMARK 465 PHE B -1 REMARK 465 GLU B 0 REMARK 465 LYS B 1 REMARK 465 THR B 2 REMARK 465 THR B 3 REMARK 465 ASN B 4 REMARK 465 ALA B 5 REMARK 465 GLY B 6 REMARK 465 ALA B 53 REMARK 465 ALA B 54 REMARK 465 VAL B 55 REMARK 465 VAL B 56 REMARK 465 PRO B 57 REMARK 465 LEU B 58 REMARK 465 GLY B 59 REMARK 465 ALA B 220 REMARK 465 LYS B 221 REMARK 465 ALA B 222 REMARK 465 THR B 223 REMARK 465 LYS B 224 REMARK 465 ALA B 225 REMARK 465 LYS B 226 REMARK 465 SER B 227 REMARK 465 LYS B 228 REMARK 465 LYS B 229 REMARK 465 ASN B 230 REMARK 465 MET C -7 REMARK 465 TRP C -6 REMARK 465 SER C -5 REMARK 465 HIS C -4 REMARK 465 PRO C -3 REMARK 465 GLN C -2 REMARK 465 PHE C -1 REMARK 465 GLU C 0 REMARK 465 LYS C 1 REMARK 465 THR C 2 REMARK 465 THR C 3 REMARK 465 ASN C 4 REMARK 465 ALA C 5 REMARK 465 GLY C 6 REMARK 465 ALA C 53 REMARK 465 ALA C 54 REMARK 465 VAL C 55 REMARK 465 VAL C 56 REMARK 465 PRO C 57 REMARK 465 LEU C 58 REMARK 465 GLY C 59 REMARK 465 ALA C 220 REMARK 465 LYS C 221 REMARK 465 ALA C 222 REMARK 465 THR C 223 REMARK 465 LYS C 224 REMARK 465 ALA C 225 REMARK 465 LYS C 226 REMARK 465 SER C 227 REMARK 465 LYS C 228 REMARK 465 LYS C 229 REMARK 465 ASN C 230 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD1 ILE B 75 C16 CTX B 301 1.49 REMARK 500 CD1 ILE B 75 C15 CTX B 301 1.96 REMARK 500 O GLN C 143 NH2 ARG C 147 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 13 87.87 -62.49 REMARK 500 TYR A 86 40.02 -101.99 REMARK 500 ASP A 89 -75.47 -73.23 REMARK 500 PHE A 96 2.06 -69.94 REMARK 500 SER A 109 -176.33 -69.59 REMARK 500 LEU A 141 46.30 -73.99 REMARK 500 ARG A 142 14.82 58.56 REMARK 500 TRP A 196 2.80 -68.63 REMARK 500 PRO B 13 84.08 -61.79 REMARK 500 TYR B 86 32.86 -99.98 REMARK 500 GLU B 88 58.29 -110.86 REMARK 500 SER B 109 -177.23 -67.44 REMARK 500 TYR B 111 3.57 -68.08 REMARK 500 LEU B 128 -61.01 -96.15 REMARK 500 GLN B 143 17.07 57.82 REMARK 500 PHE B 187 -60.83 -90.49 REMARK 500 HIS C 9 149.46 -171.90 REMARK 500 PRO C 13 88.19 -62.62 REMARK 500 GLU C 88 61.97 -109.03 REMARK 500 PHE C 96 2.74 -68.55 REMARK 500 SER C 109 -175.62 -68.81 REMARK 500 TYR C 111 2.08 -69.43 REMARK 500 LEU C 128 -60.19 -95.55 REMARK 500 GLN C 143 8.55 53.78 REMARK 500 HIS C 144 145.28 -37.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR C 11 TRP C 12 -147.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CTX A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CTX C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CTX B 301 and ILE B REMARK 800 75 DBREF 6OHU A 2 230 UNP Q15125 EBP_HUMAN 2 230 DBREF 6OHU B 2 230 UNP Q15125 EBP_HUMAN 2 230 DBREF 6OHU C 2 230 UNP Q15125 EBP_HUMAN 2 230 SEQADV 6OHU MET A -7 UNP Q15125 INITIATING METHIONINE SEQADV 6OHU TRP A -6 UNP Q15125 EXPRESSION TAG SEQADV 6OHU SER A -5 UNP Q15125 EXPRESSION TAG SEQADV 6OHU HIS A -4 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PRO A -3 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLN A -2 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PHE A -1 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLU A 0 UNP Q15125 EXPRESSION TAG SEQADV 6OHU LYS A 1 UNP Q15125 EXPRESSION TAG SEQADV 6OHU MET B -7 UNP Q15125 INITIATING METHIONINE SEQADV 6OHU TRP B -6 UNP Q15125 EXPRESSION TAG SEQADV 6OHU SER B -5 UNP Q15125 EXPRESSION TAG SEQADV 6OHU HIS B -4 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PRO B -3 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLN B -2 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PHE B -1 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLU B 0 UNP Q15125 EXPRESSION TAG SEQADV 6OHU LYS B 1 UNP Q15125 EXPRESSION TAG SEQADV 6OHU MET C -7 UNP Q15125 INITIATING METHIONINE SEQADV 6OHU TRP C -6 UNP Q15125 EXPRESSION TAG SEQADV 6OHU SER C -5 UNP Q15125 EXPRESSION TAG SEQADV 6OHU HIS C -4 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PRO C -3 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLN C -2 UNP Q15125 EXPRESSION TAG SEQADV 6OHU PHE C -1 UNP Q15125 EXPRESSION TAG SEQADV 6OHU GLU C 0 UNP Q15125 EXPRESSION TAG SEQADV 6OHU LYS C 1 UNP Q15125 EXPRESSION TAG SEQRES 1 A 238 MET TRP SER HIS PRO GLN PHE GLU LYS THR THR ASN ALA SEQRES 2 A 238 GLY PRO LEU HIS PRO TYR TRP PRO GLN HIS LEU ARG LEU SEQRES 3 A 238 ASP ASN PHE VAL PRO ASN ASP ARG PRO THR TRP HIS ILE SEQRES 4 A 238 LEU ALA GLY LEU PHE SER VAL THR GLY VAL LEU VAL VAL SEQRES 5 A 238 THR THR TRP LEU LEU SER GLY ARG ALA ALA VAL VAL PRO SEQRES 6 A 238 LEU GLY THR TRP ARG ARG LEU SER LEU CYS TRP PHE ALA SEQRES 7 A 238 VAL CYS GLY PHE ILE HIS LEU VAL ILE GLU GLY TRP PHE SEQRES 8 A 238 VAL LEU TYR TYR GLU ASP LEU LEU GLY ASP GLN ALA PHE SEQRES 9 A 238 LEU SER GLN LEU TRP LYS GLU TYR ALA LYS GLY ASP SER SEQRES 10 A 238 ARG TYR ILE LEU GLY ASP ASN PHE THR VAL CYS MET GLU SEQRES 11 A 238 THR ILE THR ALA CYS LEU TRP GLY PRO LEU SER LEU TRP SEQRES 12 A 238 VAL VAL ILE ALA PHE LEU ARG GLN HIS PRO LEU ARG PHE SEQRES 13 A 238 ILE LEU GLN LEU VAL VAL SER VAL GLY GLN ILE TYR GLY SEQRES 14 A 238 ASP VAL LEU TYR PHE LEU THR GLU HIS ARG ASP GLY PHE SEQRES 15 A 238 GLN HIS GLY GLU LEU GLY HIS PRO LEU TYR PHE TRP PHE SEQRES 16 A 238 TYR PHE VAL PHE MET ASN ALA LEU TRP LEU VAL LEU PRO SEQRES 17 A 238 GLY VAL LEU VAL LEU ASP ALA VAL LYS HIS LEU THR HIS SEQRES 18 A 238 ALA GLN SER THR LEU ASP ALA LYS ALA THR LYS ALA LYS SEQRES 19 A 238 SER LYS LYS ASN SEQRES 1 B 238 MET TRP SER HIS PRO GLN PHE GLU LYS THR THR ASN ALA SEQRES 2 B 238 GLY PRO LEU HIS PRO TYR TRP PRO GLN HIS LEU ARG LEU SEQRES 3 B 238 ASP ASN PHE VAL PRO ASN ASP ARG PRO THR TRP HIS ILE SEQRES 4 B 238 LEU ALA GLY LEU PHE SER VAL THR GLY VAL LEU VAL VAL SEQRES 5 B 238 THR THR TRP LEU LEU SER GLY ARG ALA ALA VAL VAL PRO SEQRES 6 B 238 LEU GLY THR TRP ARG ARG LEU SER LEU CYS TRP PHE ALA SEQRES 7 B 238 VAL CYS GLY PHE ILE HIS LEU VAL ILE GLU GLY TRP PHE SEQRES 8 B 238 VAL LEU TYR TYR GLU ASP LEU LEU GLY ASP GLN ALA PHE SEQRES 9 B 238 LEU SER GLN LEU TRP LYS GLU TYR ALA LYS GLY ASP SER SEQRES 10 B 238 ARG TYR ILE LEU GLY ASP ASN PHE THR VAL CYS MET GLU SEQRES 11 B 238 THR ILE THR ALA CYS LEU TRP GLY PRO LEU SER LEU TRP SEQRES 12 B 238 VAL VAL ILE ALA PHE LEU ARG GLN HIS PRO LEU ARG PHE SEQRES 13 B 238 ILE LEU GLN LEU VAL VAL SER VAL GLY GLN ILE TYR GLY SEQRES 14 B 238 ASP VAL LEU TYR PHE LEU THR GLU HIS ARG ASP GLY PHE SEQRES 15 B 238 GLN HIS GLY GLU LEU GLY HIS PRO LEU TYR PHE TRP PHE SEQRES 16 B 238 TYR PHE VAL PHE MET ASN ALA LEU TRP LEU VAL LEU PRO SEQRES 17 B 238 GLY VAL LEU VAL LEU ASP ALA VAL LYS HIS LEU THR HIS SEQRES 18 B 238 ALA GLN SER THR LEU ASP ALA LYS ALA THR LYS ALA LYS SEQRES 19 B 238 SER LYS LYS ASN SEQRES 1 C 238 MET TRP SER HIS PRO GLN PHE GLU LYS THR THR ASN ALA SEQRES 2 C 238 GLY PRO LEU HIS PRO TYR TRP PRO GLN HIS LEU ARG LEU SEQRES 3 C 238 ASP ASN PHE VAL PRO ASN ASP ARG PRO THR TRP HIS ILE SEQRES 4 C 238 LEU ALA GLY LEU PHE SER VAL THR GLY VAL LEU VAL VAL SEQRES 5 C 238 THR THR TRP LEU LEU SER GLY ARG ALA ALA VAL VAL PRO SEQRES 6 C 238 LEU GLY THR TRP ARG ARG LEU SER LEU CYS TRP PHE ALA SEQRES 7 C 238 VAL CYS GLY PHE ILE HIS LEU VAL ILE GLU GLY TRP PHE SEQRES 8 C 238 VAL LEU TYR TYR GLU ASP LEU LEU GLY ASP GLN ALA PHE SEQRES 9 C 238 LEU SER GLN LEU TRP LYS GLU TYR ALA LYS GLY ASP SER SEQRES 10 C 238 ARG TYR ILE LEU GLY ASP ASN PHE THR VAL CYS MET GLU SEQRES 11 C 238 THR ILE THR ALA CYS LEU TRP GLY PRO LEU SER LEU TRP SEQRES 12 C 238 VAL VAL ILE ALA PHE LEU ARG GLN HIS PRO LEU ARG PHE SEQRES 13 C 238 ILE LEU GLN LEU VAL VAL SER VAL GLY GLN ILE TYR GLY SEQRES 14 C 238 ASP VAL LEU TYR PHE LEU THR GLU HIS ARG ASP GLY PHE SEQRES 15 C 238 GLN HIS GLY GLU LEU GLY HIS PRO LEU TYR PHE TRP PHE SEQRES 16 C 238 TYR PHE VAL PHE MET ASN ALA LEU TRP LEU VAL LEU PRO SEQRES 17 C 238 GLY VAL LEU VAL LEU ASP ALA VAL LYS HIS LEU THR HIS SEQRES 18 C 238 ALA GLN SER THR LEU ASP ALA LYS ALA THR LYS ALA LYS SEQRES 19 C 238 SER LYS LYS ASN HET CTX A 301 28 HET CTX B 301 28 HET CTX C 301 28 HETNAM CTX (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N- HETNAM 2 CTX DIMETHYLETHANAMINE HETSYN CTX TRANS FORM OF TAMOXIFEN FORMUL 4 CTX 3(C26 H29 N O) HELIX 1 AA1 PRO A 27 ARG A 52 1 26 HELIX 2 AA2 TRP A 61 VAL A 78 1 18 HELIX 3 AA3 VAL A 78 TYR A 86 1 9 HELIX 4 AA4 ALA A 95 GLY A 107 1 13 HELIX 5 AA5 ASP A 115 LEU A 128 1 14 HELIX 6 AA6 LEU A 128 PHE A 140 1 13 HELIX 7 AA7 PRO A 145 ASP A 172 1 28 HELIX 8 AA8 PHE A 189 LEU A 218 1 30 HELIX 9 AA9 PRO B 27 ARG B 52 1 26 HELIX 10 AB1 TRP B 61 VAL B 78 1 18 HELIX 11 AB2 VAL B 78 TYR B 87 1 10 HELIX 12 AB3 ALA B 95 GLY B 107 1 13 HELIX 13 AB4 ASP B 115 LEU B 128 1 14 HELIX 14 AB5 LEU B 128 PHE B 140 1 13 HELIX 15 AB6 LEU B 146 ASP B 172 1 27 HELIX 16 AB7 PHE B 189 THR B 217 1 29 HELIX 17 AB8 PRO C 27 ARG C 52 1 26 HELIX 18 AB9 TRP C 61 VAL C 78 1 18 HELIX 19 AC1 VAL C 78 TYR C 87 1 10 HELIX 20 AC2 ALA C 95 GLY C 107 1 13 HELIX 21 AC3 ASP C 115 LEU C 128 1 14 HELIX 22 AC4 LEU C 128 PHE C 140 1 13 HELIX 23 AC5 LEU C 146 ASP C 172 1 27 HELIX 24 AC6 PHE C 189 LEU C 218 1 30 CISPEP 1 TYR B 87 GLU B 88 0 -2.84 CISPEP 2 TYR C 87 GLU C 88 0 0.58 SITE 1 AC1 12 LEU A 35 PHE A 36 THR A 39 ILE A 75 SITE 2 AC1 12 ILE A 79 GLU A 80 LEU A 100 TRP A 101 SITE 3 AC1 12 TYR A 188 MET A 192 ASN A 193 TRP A 196 SITE 1 AC2 11 LEU C 35 THR C 39 ILE C 75 ILE C 79 SITE 2 AC2 11 GLU C 80 TYR C 111 GLU C 122 TYR C 188 SITE 3 AC2 11 MET C 192 ASN C 193 TRP C 196 SITE 1 AC3 14 LEU B 35 VAL B 71 CYS B 72 GLY B 73 SITE 2 AC3 14 PHE B 74 HIS B 76 LEU B 77 ILE B 79 SITE 3 AC3 14 GLU B 80 TYR B 111 TYR B 188 MET B 192 SITE 4 AC3 14 ASN B 193 TRP B 196 CRYST1 192.837 66.829 98.678 90.00 90.00 90.00 P 21 21 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005186 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014964 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010134 0.00000